Jay R. Venkatesan
2023
In 2023, Jay R. Venkatesan earned a total compensation of $2.4M as former Chief Executive Officer, President, and Chairman of the Angion Board at Elicio Therapeutics, a 60% increase compared to previous year.
Compensation breakdown
| Bonus | $608,000 |
|---|---|
| Option Awards | $22,427 |
| Salary | $243,944 |
| Other | $1,554,904 |
| Total | $2,429,275 |
Venkatesan received $1.6M in other compensation, accounting for 64% of the total pay in 2023.
Venkatesan also received $608K in bonus, $22.4K in option awards and $243.9K in salary.
Rankings
In 2023, Jay R. Venkatesan's compensation ranked 396th out of 2,647 executives tracked by ExecPay. In other words, Venkatesan earned more than 85.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 396 out of 2,647 | 85th |
Division Manufacturing | 225 out of 1,447 | 85th |
Major group Chemicals And Allied Products | 159 out of 817 | 81st |
Industry group Drugs | 156 out of 783 | 80th |
Industry Pharmaceutical Preparations | 96 out of 555 | 83rd |
Source: SEC filing on September 27, 2024.
Venkatesan's colleagues
We found four more compensation records of executives who worked with Jay R. Venkatesan at Elicio Therapeutics in 2023.